Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study
- PMID: 25269698
- PMCID: PMC4200028
- DOI: 10.1093/jnci/dju252
Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study
Abstract
Background: Data from observational studies suggest that body mass index (BMI) is causally related to esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE). However, the relationships may be affected by bias and confounding.
Methods: We used data from the Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study: 999 patients with EAC, 2061 patients with BE, and 2169 population controls. We applied the two-stage control function instrumental variable method of the Mendelian randomization approach to estimate the unbiased, unconfounded effect of BMI on risk of EAC and BE. This was performed using a genetic risk score, derived from 29 genetic variants shown to be associated with BMI, as an instrument for lifetime BMI. A higher score indicates propensity to obesity. All tests were two-sided.
Results: The genetic risk score was not associated with potential confounders, including gastroesophageal reflux symptoms and smoking. In the instrumental variable analyses (IV), EAC risk increased by 16% (IV-odds ratio [OR] = 1.16, 95% confidence interval [CI] = 1.01 to 1.33) and BE risk increased by 12% (IV-OR = 1.12, 95% CI = 1.00 to 1.25) per 1kg/m(2) increase in BMI. BMI was statistically significantly associated with EAC and BE in conventional epidemiologic analyses.
Conclusions: People with a high genetic propensity to obesity have higher risks of esophageal metaplasia and neoplasia than people with low genetic propensity. These analyses provide the strongest evidence to date that obesity is independently associated with BE and EAC, and is not due to confounding or bias inherent in conventional epidemiologic analyses.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma.J Natl Cancer Inst. 2014 Sep 30;106(11):dju299. doi: 10.1093/jnci/dju299. Print 2014 Nov. J Natl Cancer Inst. 2014. PMID: 25269700 No abstract available.
Similar articles
-
Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.Gastroenterology. 2018 Apr;154(5):1273-1281.e3. doi: 10.1053/j.gastro.2017.12.003. Epub 2017 Dec 13. Gastroenterology. 2018. PMID: 29247777 Free PMC article.
-
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1. Clin Gastroenterol Hepatol. 2019. PMID: 30716477 Free PMC article.
-
Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization.Clin Gastroenterol Hepatol. 2014 Oct;12(10):1667-76.e1. doi: 10.1016/j.cgh.2014.01.039. Epub 2014 Feb 12. Clin Gastroenterol Hepatol. 2014. PMID: 24530603 Free PMC article.
-
Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.Gastroenterol Clin North Am. 2015 Jun;44(2):203-31. doi: 10.1016/j.gtc.2015.02.001. Epub 2015 Apr 9. Gastroenterol Clin North Am. 2015. PMID: 26021191 Free PMC article. Review.
-
Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.Dis Esophagus. 2009;22(7):571-87. doi: 10.1111/j.1442-2050.2009.00947.x. Epub 2009 Feb 13. Dis Esophagus. 2009. PMID: 19222528 Free PMC article. Review.
Cited by
-
Association between Self-Perception of Chewing, Chewing Behavior, and the Presence of Gastrointestinal Symptoms in Candidates for Bariatric Surgery.Nutrients. 2024 Apr 9;16(8):1096. doi: 10.3390/nu16081096. Nutrients. 2024. PMID: 38674787 Free PMC article.
-
The causal associations of circulating lipids with Barrett's Esophagus and Esophageal Cancer: a bi-directional, two sample mendelian randomization analysis.Hum Genomics. 2024 Apr 16;18(1):37. doi: 10.1186/s40246-024-00608-6. Hum Genomics. 2024. PMID: 38627859 Free PMC article.
-
Artificially sweetened beverages consumption and risk of obesity-related cancers: a wide-angled Mendelian randomization study.Front Nutr. 2024 Mar 6;11:1347724. doi: 10.3389/fnut.2024.1347724. eCollection 2024. Front Nutr. 2024. PMID: 38524848 Free PMC article.
-
Obesity, Dietary Fats, and Gastrointestinal Cancer Risk-Potential Mechanisms Relating to Lipid Metabolism and Inflammation.Metabolites. 2024 Jan 10;14(1):42. doi: 10.3390/metabo14010042. Metabolites. 2024. PMID: 38248845 Free PMC article. Review.
-
Age-period-cohort analysis of incidence, mortality and disability-adjusted life years of esophageal cancer in global, regional and national regions from 1990 to 2019.BMC Public Health. 2024 Jan 17;24(1):212. doi: 10.1186/s12889-024-17706-8. BMC Public Health. 2024. PMID: 38233775 Free PMC article.
References
-
- Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23(12):3155–3162 - PubMed
-
- Edgren G, Adami HO, Weiderpass E, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406–1414 - PubMed
-
- American Cancer Society. Cancer Facts and Figures 2012. Atlanta: American Cancer Society; 2012
-
- Surveillance Epidemiology and End Results (SEER) Program. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2011 Sub (1973–2010) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969–2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. 2012.
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917 - PubMed
Publication types
MeSH terms
Grants and funding
- K05 CA124911/CA/NCI NIH HHS/United States
- R01CA136725/CA/NCI NIH HHS/United States
- NIDDK 02956/PHS HHS/United States
- P01 CA091955/CA/NCI NIH HHS/United States
- R01 CA136725/CA/NCI NIH HHS/United States
- P01CA091955/CA/NCI NIH HHS/United States
- R01DK63616/DK/NIDDK NIH HHS/United States
- U01CA57923/CA/NCI NIH HHS/United States
- K05CA124911/CA/NCI NIH HHS/United States
- U01 CA057949-03/CA/NCI NIH HHS/United States
- U01CA57983/CA/NCI NIH HHS/United States
- R01CA100264/CA/NCI NIH HHS/United States
- U01CA57949/CA/NCI NIH HHS/United States
- P30CA016672/CA/NCI NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- R01CA133996/CA/NCI NIH HHS/United States
- P50CA093459/CA/NCI NIH HHS/United States
- R01CA072866/CA/NCI NIH HHS/United States
- R01CA57947/CA/NCI NIH HHS/United States
- R01 CA072866/CA/NCI NIH HHS/United States
- R01CA59636/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical